Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,559,504
-
Share change
-
-1,145,695
-
Total reported value
-
$52,053,058
-
Put/Call ratio
-
3391%
-
Price per share
-
$1.35
-
Number of holders
-
91
-
Value change
-
-$2,053,043
-
Number of buys
-
40
-
Number of sells
-
44
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q4 2016
As of 31 Dec 2016,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,559,504 shares.
The largest 10 holders included
BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., PINNACLE ASSOCIATES LTD, FMR LLC, and STATE STREET CORP.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.